Lafora Disease: A Perspective in Molecular Mechanism and Pathology

Lafora disease is a neurodegenerative disorder caused by recessive loss-of-function mutations in the EPM2A (laforin glycogen phosphatase) or EPM2B (malin E3 ubiquitin ligase) genes. Neuropathology is characterized by malformed precipitated glycogen aggregates termed Lafora bodies. Asymptomatic until adolescence, patients undergo first insidious then rapid progressive myoclonus epilepsy toward a vegetative state and death within a decade. Laforin and malin interact to regulate glycogen phosphorylation and chain length pattern, the latter critical to glycogen’s solubility. While significant gaps remain in precise mechanistic understanding, therapeutic options appear near, as partial brain glycogen synthesis prevents the disease in its genetic animal models.

No conflict of interest has been declared by the author(s).